Market Value112,320,283
Total Holdings52
File Date2024-10-03
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
QTTB / Q32 Bio Inc.
IMAB / I-Mab - Depositary Receipt (Common Stock)
MDGL / Madrigal Pharmaceuticals, Inc.
PROC / Procaps Group S.A.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
DXCM / DexCom, Inc.
PMVP / PMV Pharmaceuticals, Inc.
MRUS / Merus N.V.
OCUL / Ocular Therapeutix, Inc.
ELVN / Enliven Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
NARI / Inari Medical, Inc.
CLDX / Celldex Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
KRYS / Krystal Biotech, Inc.
EXAS / Exact Sciences Corporation
SWAV / Shockwave Medical, Inc.
AVRO / AVROBIO, Inc.
ALPN / Alpine Immune Sciences, Inc.
ITCI / Intra-Cellular Therapies, Inc.
INZY / Inozyme Pharma, Inc.
RGLS / Regulus Therapeutics Inc.
VTYX / Ventyx Biosciences, Inc.
RGNX / REGENXBIO Inc.
CABA / Cabaletta Bio, Inc.
SRPT / Sarepta Therapeutics, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
PEN / Penumbra, Inc.
BHVN / Biohaven Ltd.
TVTX / Travere Therapeutics, Inc.
INSM / Insmed Incorporated
AVDL / Avadel Pharmaceuticals plc
MASI / Masimo Corporation
ATEC / Alphatec Holdings, Inc.
ELEV / Elevation Oncology, Inc.
ABCL / AbCellera Biologics Inc.
FULC / Fulcrum Therapeutics, Inc.
HLVX / HilleVax, Inc.
VYNE / VYNE Therapeutics Inc.
AMGN / Amgen Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RZLT / Rezolute, Inc.
GERN / Geron Corporation
GH / Guardant Health, Inc.
IRON / Disc Medicine, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
RARE / Ultragenyx Pharmaceutical Inc.
CYTK / Cytokinetics, Incorporated
WVE / Wave Life Sciences Ltd.
AGIO / Agios Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
ADAG / Adagene Inc. - Depositary Receipt (Common Stock)
SGMT / Sagimet Biosciences Inc.
BIIB / Biogen Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TGTX / TG Therapeutics, Inc.
ARVN / Arvinas, Inc.
PLRX / Pliant Therapeutics, Inc.
APRE / Aprea Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
TECX / Tectonic Therapeutic, Inc.
NTRA / Natera, Inc.
ALVO / Alvotech
LLY / Eli Lilly and Company
ISRG / Intuitive Surgical, Inc.
ESTA / Establishment Labs Holdings Inc.
CI / The Cigna Group
PACB / Pacific Biosciences of California, Inc.
QTRX / Quanterix Corporation
KURA / Kura Oncology, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
TERN / Terns Pharmaceuticals, Inc.
SYRS / Syros Pharmaceuticals, Inc.